Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-28

Clinical Trial Update: Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE) [Phase 4]

View source ↗

Summary

Phase 4 trial update on heparin prophylaxis dosing for antepartum hospitalizations in pregnancy-related conditions, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Pregnancy Related, Antepartum DVT | Phase 4 | Status: COMPLETED | Results posted: 2023-04-28